Effective and selective inhibition of chronic myeloid leukemia primitive hematopoietic progenitors by the dual Src/Abl kinase inhibitor SKI-606
Ravi Bhatia(City Of Hope National Medical Center)
Cited by 105
Related Papers
Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic Cells
|Cancer Research|2008|99
Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling
|Leukemia|2022|30
Low c-Kit expression identifies primitive, therapy-resistant CML stem cells
|JCI Insight|2022|9